Rosiglitazone activation of PPARγ suppresses fractalkine signaling
Open Access
- 22 October 2009
- journal article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 44 (2), 135-142
- https://doi.org/10.1677/jme-09-0090
Abstract
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is a key transcriptional regulator of both lipid metabolism and inflammation. The importance of PPARγ is accentuated by the widespread use of synthetic PPARγ agonists, thiazolidinediones (such as rosiglitazone), as drugs for insulin resistance and type II diabetes. Fractalkine (FKN) and FKN receptor (FR) play an important role in the immune responses by regulating leukocyte migration and adhesion to inflamed peripheral tissues. In this study, we have identified a novel link between PPARγ activation and FKN signaling. On one hand, the activation of PPARγ by rosiglitazone in macrophages not only represses the transcription of the FR gene, but also prevents the plasma membrane translocation of the FR protein. On the other hand, the activation of PPARγ by rosiglitazone in endothelial cells also impedes the nuclear export of FKN. Together, these data suggest that PPARγ activation represses FKN signaling. These findings indicate a previously unrecognized mechanism that may contribute to the anti-inflammatory effect of PPARγ.Keywords
This publication has 19 references indexed in Scilit:
- CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone TropismCancer Research, 2008
- CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degenerationJCI Insight, 2007
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milkPublished by Cold Spring Harbor Laboratory ,2007
- Macrophage-specific PPARγ controls alternative activation and improves insulin resistanceNature, 2007
- Expression of peroxisome proliferator-activated receptor-γ in macrophage suppresses experimentally induced colitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Peroxisome proliferator activated receptor in colonic epithelial cells protects against experimental inflammatory bowel diseaseGut, 2005
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissueClinical and Experimental Immunology, 2005
- Cloning and functional characterization of the human fractalkine receptor promoter regionsBiochemical Journal, 2002
- Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseBlood, 2001